Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk ...Middle East

Medscape - News
Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients with relapsing-remitting multiple sclerosis. But adverse events are common. Medscape Medical News

Hence then, the article about stem cell transplant trumps fingolimod for rrms relapse risk was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News